StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Earnings

Regen BioPharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Regen BioPharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2024ended Sep 30, 2024Nov 29, 2024before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Regen BioPharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Regen BioPharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Regen BioPharma filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?